CVS Health Corp has 4.94% upside potential, based on the analysts' average price target. Is CVS a Buy, Sell or Hold? CVS Health Corp has a consensus rating of Moderate Buy which is based on 9 buy ratings, 5 hold ratings and 0 sell ratings.
22 сент. 2024 г. · That's why, in my view, for investors looking beyond the next five years, it is still worth it to consider investing in CVS Health. |
65,36 $ The financial health and growth prospects of CVS, demonstrate its potential to outperform the market. It currently has a Growth Score of D. Recent price changes ... |
15 авг. 2024 г. · From a valuation perspective, CVS looks like it has ample room for growth. We estimate CVS Health's Valuation to be $66 per share, reflecting ... |
8 дней назад · In the past five years, CVS stock has achieved a dispappointing total return of just 14%, dramatically lagging the market's growth of 110%. So ... |
Оценка 3,7  · StockInvest.us The CVS Health stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader ... |
Оценка 4,2  (15) The consensus among 15 Wall Street analysts covering (NYSE: CVS) stock is to Buy CVS stock. Out of 15 analysts, 8 (53.33%) are recommending CVS as a Strong Buy, ... |
Оценка 5,0  (31) The stock has been described as undervalued by multiple experts, with potential for long-term growth and profitability. |
16 сент. 2024 г. · CVS Health currently has an average brokerage recommendation (ABR) of 1.98, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based ... |
3 сент. 2024 г. · CVS Shares Are Expensive In terms of valuation too, CVS Health's forward 12-month price-to-earnings (P/E) is 8.09X, a premium to the market's ... |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |